Therus Corporation is developing the Therus® Acoustic Hemostasis System, a medical device designed for rapid, durable, noninvasive sealing of femoral artery access punctures following catheterization-laboratory procedures such as angiography and angioplasty.
While the Company is pursuing femoral artery sealing, there are numerous other potential clinical applications for therapeutic ultrasound. These applications are being evaluated by AcousTx Corporation, a spinoff company of Therus. The product launch is planned for 2008.
While the Company is pursuing femoral artery sealing, there are numerous other potential clinical applications for therapeutic ultrasound. These applications are being evaluated by AcousTx Corporation, a spinoff company of Therus. The product launch is planned for 2008.
No comments:
Post a Comment